+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biochips Market Research Report by Fabrication Technology, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4857855
  • Report
  • July 2021
  • Region: Global
  • 180 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Biochips Market will Grow to USD 94.98 Billion by 2026, at a CAGR of 21.01%

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • MORE
The Global Biochips Market size was estimated at USD 30.24 Billion in 2020 and expected to reach USD 36.49 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 21.01% to reach USD 94.98 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biochips to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Fabrication Technology, the Biochips Market was studied across Microarrays and Microfluidics.
  • Based on Type, the Biochips Market was studied across Arrays, DNA Chips, Lab-On-A-Chip, and Protein Chips. The Arrays is further studied across Cell Arrays and Tissue Arrays.
  • Based on Application, the Biochips Market was studied across Agricultural Biotechnology, Cancer Diagnosis & Treatment, Clinical Diagnostics, DNA Chip Applications, Diagnostics, Drug Discovery, Expression Profiling, Gene Expression, Genomics, High-Throughput Screening, IVD & POC, Proteomics, and SNP Genotyping.
  • Based on End User, the Biochips Market was studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Diagnostics Centers.
  • Based on Region, the Biochips Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biochips Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biochips Market, including Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Cepheid Inc., Fluidigm Corporation, GE Healthcare, Illumina, Inc., Perkinelmer, Inc., Roche Diagnostics, and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Biochips Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biochips Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biochips Market?
4. What is the competitive strategic window for opportunities in the Global Biochips Market?
5. What are the technology trends and regulatory frameworks in the Global Biochips Market?
6. What is the market share of the leading vendors in the Global Biochips Market?
7. What modes and strategic moves are considered suitable for entering the Global Biochips Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Fabrication Technology Outlook
3.4. Type Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of life-threatening disorder and rise in geriatric population
5.1.1.2. Demand of personalized adoption owing to increase adoption
5.1.1.3. Large number of biochips applications
5.1.2. Restraints
5.1.2.1. Limited awareness in developing economies
5.1.2.2. Loosely defined regulatory guidelines
5.1.3. Opportunities
5.1.3.1. Potential in untapped developed regions
5.1.3.2. Safe and economical alternative to animal testing
5.1.4. Challenges
5.1.4.1. High cost associated with biochips
5.1.4.2. Complexity associated with the biological system
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Biochips Market, by Fabrication Technology
6.1. Introduction
6.2. Microarrays
6.3. Microfluidics

7. Biochips Market, by Type
7.1. Introduction
7.2. Arrays
7.2.1. Cell Arrays
7.2.2. Tissue Arrays
7.3. DNA Chips
7.4. Lab-On-A-Chip
7.5. Protein Chips

8. Biochips Market, by Application
8.1. Introduction
8.2. Agricultural Biotechnology
8.3. Cancer Diagnosis & Treatment
8.4. Clinical Diagnostics
8.5. DNA Chip Applications
8.6. Diagnostics
8.7. Drug Discovery
8.8. Expression Profiling
8.9. Gene Expression
8.10. Genomics
8.11. High-Throughput Screening
8.12. IVD & POC
8.13. Proteomics
8.14. SNP Genotyping

9. Biochips Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology & Pharmaceutical Companies
9.4. Hospitals & Diagnostics Centers

10. Americas Biochips Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Biochips Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa Biochips Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Agilent Technologies, Inc.
14.3. Bio-Rad Laboratories Inc.
14.4. Cepheid Inc.
14.5. Fluidigm Corporation
14.6. GE Healthcare
14.7. Illumina, Inc.
14.8. Perkinelmer, Inc.
14.9. Roche Diagnostics
14.10. Thermo Fisher Scientific, Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL BIOCHIPS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2020 (USD BILLION)
FIGURE 3. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2020 (USD BILLION)
FIGURE 4. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 5. GLOBAL BIOCHIPS MARKET SIZE, BY END USER, 2020 (USD BILLION)
FIGURE 6. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 7. GLOBAL BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL BIOCHIPS MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL BIOCHIPS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 11. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2020 VS 2026 (USD BILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2026
FIGURE 13. GLOBAL BIOCHIPS MARKET SIZE, BY MICROARRAYS, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL BIOCHIPS MARKET SIZE, BY MICROARRAYS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 18. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2026
FIGURE 20. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL BIOCHIPS MARKET SIZE, BY CELL ARRAYS, 2018-2026 (USD BILLION)
FIGURE 23. GLOBAL BIOCHIPS MARKET SIZE, BY CELL ARRAYS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 24. GLOBAL BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, 2018-2026 (USD BILLION)
FIGURE 25. GLOBAL BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 26. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIPS, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIPS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 28. GLOBAL BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, 2018-2026 (USD BILLION)
FIGURE 29. GLOBAL BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 30. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, 2018-2026 (USD BILLION)
FIGURE 31. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 32. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 33. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2026
FIGURE 35. GLOBAL BIOCHIPS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2026 (USD BILLION)
FIGURE 36. GLOBAL BIOCHIPS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 37. GLOBAL BIOCHIPS MARKET SIZE, BY CANCER DIAGNOSIS & TREATMENT, 2018-2026 (USD BILLION)
FIGURE 38. GLOBAL BIOCHIPS MARKET SIZE, BY CANCER DIAGNOSIS & TREATMENT, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 39. GLOBAL BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2026 (USD BILLION)
FIGURE 40. GLOBAL BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 41. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIP APPLICATIONS, 2018-2026 (USD BILLION)
FIGURE 42. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIP APPLICATIONS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 43. GLOBAL BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2026 (USD BILLION)
FIGURE 44. GLOBAL BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 45. GLOBAL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2026 (USD BILLION)
FIGURE 46. GLOBAL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 47. GLOBAL BIOCHIPS MARKET SIZE, BY EXPRESSION PROFILING, 2018-2026 (USD BILLION)
FIGURE 48. GLOBAL BIOCHIPS MARKET SIZE, BY EXPRESSION PROFILING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 49. GLOBAL BIOCHIPS MARKET SIZE, BY GENE EXPRESSION, 2018-2026 (USD BILLION)
FIGURE 50. GLOBAL BIOCHIPS MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 51. GLOBAL BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2026 (USD BILLION)
FIGURE 52. GLOBAL BIOCHIPS MARKET SIZE, BY GENOMICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 53. GLOBAL BIOCHIPS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, 2018-2026 (USD BILLION)
FIGURE 54. GLOBAL BIOCHIPS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 55. GLOBAL BIOCHIPS MARKET SIZE, BY IVD & POC, 2018-2026 (USD BILLION)
FIGURE 56. GLOBAL BIOCHIPS MARKET SIZE, BY IVD & POC, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 57. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2026 (USD BILLION)
FIGURE 58. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEOMICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 59. GLOBAL BIOCHIPS MARKET SIZE, BY SNP GENOTYPING, 2018-2026 (USD BILLION)
FIGURE 60. GLOBAL BIOCHIPS MARKET SIZE, BY SNP GENOTYPING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 61. GLOBAL BIOCHIPS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 62. GLOBAL BIOCHIPS MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOCHIPS MARKET SIZE, BY END USER, 2026
FIGURE 64. GLOBAL BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD BILLION)
FIGURE 65. GLOBAL BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 66. GLOBAL BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2026 (USD BILLION)
FIGURE 67. GLOBAL BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 68. GLOBAL BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, 2018-2026 (USD BILLION)
FIGURE 69. GLOBAL BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 70. AMERICAS BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 71. ARGENTINA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 72. BRAZIL BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 73. CANADA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 74. MEXICO BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 75. UNITED STATES BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 76. ASIA-PACIFIC BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 77. AUSTRALIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 78. CHINA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 79. INDIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 80. INDONESIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 81. JAPAN BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 82. MALAYSIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 83. PHILIPPINES BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 84. SINGAPORE BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 85. SOUTH KOREA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 86. THAILAND BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 87. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 88. FRANCE BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 89. GERMANY BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 90. ITALY BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 91. NETHERLANDS BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 92. QATAR BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 93. RUSSIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 94. SAUDI ARABIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 95. SOUTH AFRICA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 96. SPAIN BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 97. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 98. UNITED KINGDOM BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 99. GLOBAL BIOCHIPS MARKET: FPNV POSITIONING MATRIX
FIGURE 100. GLOBAL BIOCHIPS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 101. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOCHIPS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL BIOCHIPS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL BIOCHIPS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL BIOCHIPS MARKET SIZE, BY CELL ARRAYS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIPS, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL BIOCHIPS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL BIOCHIPS MARKET SIZE, BY CANCER DIAGNOSIS & TREATMENT, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIP APPLICATIONS, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2026 (USD BILLION)
TABLE 21. GLOBAL BIOCHIPS MARKET SIZE, BY EXPRESSION PROFILING, BY REGION, 2018-2026 (USD BILLION)
TABLE 22. GLOBAL BIOCHIPS MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2026 (USD BILLION)
TABLE 23. GLOBAL BIOCHIPS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 24. GLOBAL BIOCHIPS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2026 (USD BILLION)
TABLE 25. GLOBAL BIOCHIPS MARKET SIZE, BY IVD & POC, BY REGION, 2018-2026 (USD BILLION)
TABLE 26. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 27. GLOBAL BIOCHIPS MARKET SIZE, BY SNP GENOTYPING, BY REGION, 2018-2026 (USD BILLION)
TABLE 28. GLOBAL BIOCHIPS MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 29. GLOBAL BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2026 (USD BILLION)
TABLE 30. GLOBAL BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 31. GLOBAL BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 32. AMERICAS BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. ARGENTINA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. BRAZIL BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. CANADA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. MEXICO BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. UNITED STATES BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. ASIA-PACIFIC BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. AUSTRALIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. CHINA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. INDIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. INDONESIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. JAPAN BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. MALAYSIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. PHILIPPINES BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. SINGAPORE BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. SOUTH KOREA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. THAILAND BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 50. FRANCE BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 51. GERMANY BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 52. ITALY BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 53. NETHERLANDS BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 54. QATAR BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 55. RUSSIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 56. SAUDI ARABIA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 57. SOUTH AFRICA BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 58. SPAIN BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 59. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 60. UNITED KINGDOM BIOCHIPS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 61. GLOBAL BIOCHIPS MARKET: SCORES
TABLE 62. GLOBAL BIOCHIPS MARKET: BUSINESS STRATEGY
TABLE 63. GLOBAL BIOCHIPS MARKET: PRODUCT SATISFACTION
TABLE 64. GLOBAL BIOCHIPS MARKET: RANKING
TABLE 65. GLOBAL BIOCHIPS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 66. GLOBAL BIOCHIPS MARKET: MERGER & ACQUISITION
TABLE 67. GLOBAL BIOCHIPS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 68. GLOBAL BIOCHIPS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 69. GLOBAL BIOCHIPS MARKET: INVESTMENT & FUNDING
TABLE 70. GLOBAL BIOCHIPS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 71. GLOBAL BIOCHIPS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll